stavudine has been researched along with Wasting Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abbey-Toby, A; Begriche, K; Chataigner, K; Colin, M; Feldmann, G; Fromenty, B; Grodet, A; Igoudjil, A; Lettéron, P; Maachi, M; Pessayre, D; Peytavin, G; Robin, MA | 1 |
1 other study(ies) available for stavudine and Wasting Disease
Article | Year |
---|---|
High doses of stavudine induce fat wasting and mild liver damage without impairing mitochondrial respiration in mice.
Topics: Adipose Tissue, White; Administration, Oral; Aminoisobutyric Acids; Animals; Carnitine; Chemical and Drug Induced Liver Injury; Fatty Acids; Hepatocytes; Ketone Bodies; Leptin; Lipodystrophy; Liver; Liver Diseases; Male; Mice; Mitochondria, Liver; Reverse Transcriptase Inhibitors; Stavudine; Stearoyl-CoA Desaturase; Transaminases; Vitamin B Complex; Wasting Syndrome | 2007 |